IDEAYA Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IDEAYA Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
  • IDEAYA Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$66.9M, a 99.5% decline year-over-year.
  • IDEAYA Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$225M, a 88.9% decline year-over-year.
  • IDEAYA Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$134M, a 115% decline from 2022.
  • IDEAYA Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$62.5M, a 24.3% decline from 2021.
  • IDEAYA Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$50.3M, a 42.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$225M -$66.9M -$33.4M -99.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$191M -$64.9M -$32.2M -98.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$159M -$51M -$24.7M -94.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$134M -$41.9M -$15.5M -58.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$119M -$33.5M -$34.2M -5180% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$84.8M -$32.7M -$10.2M -45.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$74.6M -$26.3M -$12.1M -84.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$62.5M -$26.4M -$8.07M -44% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$54.4M $660K +$12.4M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$66.8M -$22.5M -$11.4M -104% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$55.4M -$14.2M -$5.09M -55.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$50.3M -$18.4M -$13.1M -248% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$37.2M -$11.7M -$6.72M -134% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$30.5M -$11.1M +$1.54M +12.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$32M -$9.14M +$3.34M +26.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$35.3M -$5.28M +$6.04M +53.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 -$41.4M -$5M +$6.63M +57% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$48M -$12.6M -$1.36M -12.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$46.7M -$12.5M -$2.38M -23.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$44.3M -$11.3M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-18
Q3 2019 -$11.6M +$2M +14.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$11.2M -$3.66M -48.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$10.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 -$13.6M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.57M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.